Abd E, Kader T, Kubota S, Janune D, Nishida T, Hattori T, Aoyama E, Perbal B, Kuboki T, Takigawa M (2013) Anti-fibrotic effect of CCN3 accompanied by altered gene expression profile of the CCN family. J cell communication Signal 7:11–18

Article  Google Scholar 

Alami T, Liu JL (2021) Metabolic Effects of CCN5/WISP2 Gene Deficiency and transgenic overexpression in mice. Int J Mol Sci 22(24):13418

Article  CAS  PubMed  PubMed Central  Google Scholar 

Barchetta I, Cimini FA, Capoccia D, De Gioannis R, Porzia A, Mainiero F, Di Martino M, Bertoccini L, De Bernardinis M, Leonetti F, Baroni MG, Lenzi A, Cavallo MG (2017) WISP1 is a marker of systemic and adipose tissue inflammation in dysmetabolic subjects with or without type 2 diabetes. J Endocr Soc 1(6):660–670

Article  CAS  PubMed  PubMed Central  Google Scholar 

Borkham-Kamphorst E, Huss S, Van de Leur E, Haas U, Weiskirchen R (2012) Adenoviral CCN 3/NOV gene transfer fails to mitigate liver fibrosis in an experimental bile duct ligation model because of hepatocyte apoptosis. Liver International 32(9):1342–1353

Article  CAS  PubMed  Google Scholar 

Borkham-Kamphorst E, Schaffrath C, Van de Leur E, Haas U, Tihaa L, Meurer SK, Nevzorova YA, Liedtke C, Weiskirchen R (2014) The anti-fibrotic effects of CCN1/CYR61 in primary portal myofibroblasts are mediated through induction of reactive oxygen species resulting in cellular senescence, apoptosis and attenuated TGF-beta signaling. Biochim Biophys Acta 1843(5):902–914

Article  CAS  PubMed  Google Scholar 

Borkham-Kamphorst E, Steffen BT, Van de Leur E, Haas U, Tihaa L, Friedman SL, Weiskirchen R (2016) CCN1/CYR61 overexpression in hepatic stellate cells induces ER stress-related apoptosis. Cell Signal 28(1):34–42

Article  CAS  PubMed  Google Scholar 

Charrier A, Brigstock DR (2013) Regulation of pancreatic function by connective tissue growth factor (CTGF, CCN2). Cytokine Growth Factor Rev 24(1):59–68

Article  CAS  PubMed  Google Scholar 

Cheng C, Tian J, Zhang F, Deng Z, Tu M, Li L, Yang H, Xiao K, Guo W, Yang R, Gao S, Zhou Z (2021) WISP1 protects against Chondrocyte Senescence and apoptosis by regulating αvβ3 and PI3K/Akt pathway in Osteoarthritis. DNA Cell Biol 40(4):629–637

Article  CAS  PubMed  Google Scholar 

Chowdhury S, Wang X, Srikant CB, Li Q, Fu M, Gong YJ, Ning G, Liu JL (2014) IGF-I stimulates CCN5/WISP2 gene expression in pancreatic beta-cells, which promotes cell proliferation and survival against streptozotocin. Endocrinology 155(5):1629–1642

Article  PubMed  Google Scholar 

Crawford LA, Guney MA, Oh YA, Deyoung RA, Valenzuela DM, Murphy AJ, Yancopoulos GD, Lyons KM, Brigstock DR, Economides A, Gannon M (2009) Connective tissue growth factor (CTGF) inactivation leads to defects in islet cell lineage allocation and b-cell proliferation during embryogenesis. Mol Endocrinol 23(3):324–336

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dorn LE, Petrosino JM, Wright P, Accornero F (2018) CTGF/CCN2 is an autocrine regulator of cardiac fibrosis. J Mol Cell Cardiol 121:205–211

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fernandez-Ruiz R, Garcia-Alaman A, Esteban Y, Mir-Coll J, Serra-Navarro B, Fontcuberta-PiSunyer M, Broca C, Armanet M, Wojtusciszyn A, Kram V, Young MF, Vidal J, Gomis R, Gasa R (2020) Wisp1 is a circulating factor that stimulates proliferation of adult mouse and human beta cells. Nat Commun 11(1):5982

Article  CAS  PubMed  PubMed Central  Google Scholar 

Grunberg JR, Hoffmann JM, Hedjazifar S, Nerstedt A, Jenndahl L, Elvin J, Castellot J, Wei L, Moverare-Skrtic S, Ohlsson C, Holm LM, Backhed F, Syed I, Bosch F, Saghatelian A, Kahn BB, Hammarstedt A, Smith U (2017) Overexpressing the novel autocrine/endocrine adipokine WISP2 induces hyperplasia of the heart, white and brown adipose tissues and prevents insulin resistance. Sci Rep 7:43515

Article  PubMed  PubMed Central  Google Scholar 

Guney MA, Petersen CP, Boustani A, Duncan MR, Gunasekaran U, Menon R, Warfield C, Grotendorst GR, Means AL, Economides AN, Gannon M (2011) Connective tissue growth factor acts within both endothelial cells and beta cells to promote proliferation of developing beta cells. Proc Natl Acad Sci U S A 108(37):15242–15247

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hörbelt T, Tacke C, Markova M, Herzfeld de Wiza D, Van de Velde F, Bekaert M, Van Nieuwenhove Y, Hornemann S, Rödiger M, Seebeck N, Friedl E, Jonas W, Thoresen GH, Kuss O, Rosenthal A, Lange V, Pfeiffer AFH, Schürmann A, Lapauw B, Rudovich N, Pivovarova O, Ouwens DM (2018) The novel adipokine WISP1 associates with insulin resistance and impairs insulin action in human myotubes and mouse hepatocytes. Diabetologia 61(9):2054–2065

Article  PubMed  Google Scholar 

Jeong D, Lee MA, Li Y, Yang DK, Kho C, Oh JG, Hong G, Lee A, Song MH, LaRocca TJ, Chen J, Liang L, Mitsuyama S, D’Escamard V, Kovacic JC, Kwak TH, Hajjar RJ, Park WJ (2016) Matricellular Protein CCN5 reverses established Cardiac Fibrosis. J Am Coll Cardiol 67(13):1556–1568

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jian YC, Wang JJ, Dong S, Hu JW, Hu LJ, Yang GM, Zheng YX, Xiong WJ (2014) Wnt-induced secreted protein 1/CCN4 in liver fibrosis both in vitro and in vivo. Clin Lab 60(1):29–35

CAS  PubMed  Google Scholar 

Ju L, Sun Y, Xue H, Chen L, Gu C, Shao J, Lu R, Luo X, Wei J, Ma X, Bian Z (2020) CCN1 promotes hepatic steatosis and inflammation in non-alcoholic steatohepatitis. Sci Rep 10(1):3201

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kaddour N, Zhang D, Gao ZH, Liu JL (2019) Recombinant protein CCN5/WISP2 promotes islet cell proliferation and survival in vitro. Growth Factors 37(3–4):120–130

Article  CAS  PubMed  Google Scholar 

Kim KH, Chen CC, Monzon RI, Lau LF (2013) Matricellular protein CCN1 promotes regression of liver fibrosis through induction of cellular senescence in hepatic myofibroblasts. Mol Cell Biol 33(10):2078–2090

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kim J, Joo S, Eom GH, Lee SH, Lee MA, Lee M, Kim KW, Kim DH, Kook H, Kwak TH, Park WJ (2018) CCN5 knockout mice exhibit lipotoxic cardiomyopathy with mild obesity and diabetes. PLoS ONE 13(11):e0207228

Article  PubMed  PubMed Central  Google Scholar 

Klee S, Lehmann M, Wagner DE, Baarsma HA, Königshoff M (2016) WISP1 mediates IL-6-dependent proliferation in primary human lung fibroblasts. Sci Rep 6:20547

Article  CAS  PubMed  PubMed Central  Google Scholar 

Klimontov VV, Bulumbaeva DM, Fazullina ON, Lykov AP, Bgatova NP, Orlov NB, Konenkov VI, Pfeiffer AFH, Pivovarova-Ramich O, Rudovich N (2020) Circulating Wnt1-inducible signaling pathway protein-1 (WISP-1/CCN4) is a novel biomarker of adiposity in subjects with type 2 diabetes. J Cell Commun Signal 14(1):101–109

Article  PubMed  Google Scholar 

Kubota S, Kawata K, Hattori T, Nishida T (2022) Molecular and genetic interactions between CCN2 and CCN3 behind their Yin & Yang collaboration. Int J Mol Sci 23(11):5887

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kubota S, Kawaki H, Perbal B, Takigawa M, Kawata K, Hattori T, Nishida T (2023) Do not overwork: cellular communication network factor 3 for life in cartilage. J Cell Commun Signal

Kulkarni T, Kurundkar AR, Kim YI, de Andrade J, Luckhardt T, Thannickal VJ (2020) The senescence-associated matricellular protein CCN1 in plasma of human subjects with idiopathic pulmonary fibrosis. Respir Med 161:105821

Article  PubMed  Google Scholar 

Li X, Chen Y, Ye W, Tao X, Zhu J, Wu S, Lou L (2015) Blockade of CCN4 attenuates CCl4-induced liver fibrosis. Arch Med Sci 11(3):647–653

Article  PubMed  PubMed Central  Google Scholar 

Li JY, Wang YD, Qi XY, Ran L, Hong T, Yang J, Yan B, Liao ZZ, Liu JH, Xiao XH (2019) Serum CCN3 levels are increased in type 2 diabetes mellitus and associated with obesity, insulin resistance and inflammation. Clin Chim Acta 494:52–57

Article  CAS  PubMed  Google Scholar 

Liu J, Ren Y, Kang L, Zhang L (2014) Overexpression of CCN3 inhibits inflammation and progression of atherosclerosis in apolipoprotein E-deficient mice. PLoS ONE 9(4):e94912

Article  PubMed  PubMed Central  Google Scholar 

Liu JL, Kaddour N, Chowdhury S, Li Q, Gao ZH (2017) Role of CCN5 (WNT1 inducible signaling pathway protein 2) in pancreatic islets. J Diabetes 9(5):462–474

Article  CAS  PubMed  Google Scholar 

Loomba R, Friedman SL, Shulman GI (2021) Mechanisms and disease consequences of nonalcoholic fatty liver disease. Cell 184(10):2537–2564

Article  CAS  PubMed  Google Scholar 

Martinerie C, Garcia M, Do TTH, Antoine B, Moldes M, Dorothee G, Kazazian C, Auclair M, Buyse M, Ledent T, Marchal P-O, Fesatidou M, Beisseiche A, Koseki H, Hiraoka S, Chadjichristos CE, Blondeau B, Denis RG, Luquet S, Fève B (2016) NOV/CCN3: A New Adipocytokine Involved in Obesity-Associated Insulin Resistance. Diabetes 65(9): 2502–2515

Mirr M, Owecki M (2021) An update to the WISP-1/CCN4 role in obesity, insulin resistance and diabetes. Med (Kaunas) 57(2):7

Google Scholar 

Paradis R, Lazar N, Antinozzi P, Perbal B, Buteau J (2013) Nov/Ccn3, a novel transcriptional target of FoxO1, impairs pancreatic beta-cell function. PLoS ONE 8(5):e64957

Article  PubMed  PubMed Central  Google Scholar 

Pi L, Sun C, Jn-Simon N, Basha S, Thomas H, Figueroa V, Zarrinpar A, Cao Q, Petersen B (2022) CCN2/CTGF promotes liver fibrosis through crosstalk with the Slit2/Robo signaling. J Cell Commun Signal

Pivovarova-Ramich O, Loske J, Hornemann S, Markova M, Seebeck N, Rosenthal A, Klauschen F, Castro JP, Buschow R, Grune T, Lange V, Rudovich N, Ouwens DM (2021) Hepatic Wnt1 Inducible Signaling pathway protein 1 (WISP-1/CCN4) associates with markers of liver fibrosis in severe obesity. Cells 10(5):1048

Article  CAS  PubMed  PubMed Central